Effect of prenatal arsenic exposure on DNA methylation and leukocyte subpopulations in cord blood

Epigenetics

Volumn 9, Issue 5, 2014, Pages 774-782

  Kile, Molly L ^a   Andres Houseman, E ^a   Baccarelli, Andrea A ^b   Quamruzzaman, Quazi ^c   Rahman, Mahmuder ^c   Mostofa, Golam ^c   Cardenas, Andres ^a   Wright, Robert O ^d   Christiani, David C ^b  

^a OREGON STATE UNIVERSITY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Dhaka Community Hospital   (Bangladesh)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Arsenic; Cord blood; Developmental programming; DNA methylation; Immune function; Leukocytes

Indexed keywords

ARSENIC; CD151 ANTIGEN; COLLAGEN TYPE 11; SOX2 OVERLAPPING TRANSCRIPT PROTEIN; TENASCIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL 7; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; UNCLASSIFIED DRUG; UNTRANSLATED RNA; VITAMIN D RECEPTOR; ZINC FINGER PROTEIN; WATER POLLUTANT;

ARTICLE; CALCIUM AND INTEGRIN BINDING FAMILY MEMBER 4 GENE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLLAGEN TYPE 11 ALPHA 2 GENE; CPG ISLAND; DNA METHYLATION; DNA METHYLATION ASSAY; FEMALE; GENE; HUMAN; IMMUNE RESPONSE; INFINIUM HUMAN METHYLATION450 BEADCHIP ARRAY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PRENATAL DRUG EXPOSURE; RECEPTOR GENE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SOX2OT GENE; T LYMPHOCYTE SUBPOPULATION; TENASCIN XB GENE; TRANSIENT RECEPTOR POTENTIAL CHANNEL 7 GENE; UMBILICAL CORD BLOOD; VITAMIN D RECEPTOR GENE; ADVERSE EFFECTS; FETUS BLOOD; GENETIC EPIGENESIS; LEUKOCYTE; MALE; MATERNAL EXPOSURE; METABOLISM; NEWBORN; PREGNANCY; TOXICITY; WATER POLLUTANT;

ARSENIC; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; LEUKOCYTES; MALE; MATERNAL EXPOSURE; PREGNANCY; WATER POLLUTANTS, CHEMICAL;

EID: 84899833250     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.28153     Document Type: Article

References (59)

1. Mandal BK, Suzuki KT. Arsenic round the world: a review. Talanta 2002; 58:201-235. PMID:18968746; http://dx.doi.org/10.1016/S0039-9140(02)00268-0
2. Concha G, Vogler G, Lezcano D, Nermell B, Vahter M. Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci 1998; 44:185-190. PMID:9742656; http://dx.doi.org/10.1093/toxsci/44.2.185
3. Concha G, Nermell B, Vahter MV. Metabolism of inorganic arsenic in children with chronic high arsenic exposure in northern Argentina. Environ Health Perspect 1998; 106:355-9. PMID:9618352; http://dx.doi.org/10.1289/ehp.98106355
4. Guan H, Piao F, Zhang X, Li X, Li Q, Xu L, Kitamura F, Yokoyama K. Prenatal exposure to arsenic and its effects on fetal development in the general population of Dalian. Biol Trace Elem Res 2012; 149:10-5. PMID:22451376; http://dx.doi.org/10.1007/s12011-012-9396-7
5. Hall M, Gamble M, Slavkovich V, Liu X, Levy D, Cheng Z, van Geen A, Yunus M, Rahman M, Pilsner JR, et al.Determinants of arsenic metabolism: blood arsenic metabolites, plasma folate, cobalamin, and homocysteine concentrations in maternal-newborn pairs. Environ Health Perspect 2007; 115:1503-9. PMID:17938743
6. Smith AH, Marshall G, Yuan Y, Ferreccio C, Liaw J, von Ehrenstein O, Steinmaus C, Bates MN, Selvin S. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ Health Perspect 2006; 114:1293-6. PMID:16882542; http://dx.doi.org/10.1289/ehp.8832
7. Dauphiné DC, Ferreccio C, Guntur S, Yuan Y, Hammond SK, Balmes J, Smith AH, Steinmaus C. Lung function in adults following in utero and childhood exposure to arsenic in drinking water: preliminary findings. Int Arch Occup Environ Health 2011; 84:591-600. PMID:20972800; http://dx.doi.org/10.1007/s00420-010-0591-6
8. Yorifuji T, Tsuda T, Doi H, Grandjean P. Cancer excess after arsenic exposure from contaminated milk powder. Environ Health Prev Med 2011; 16:164-170. PMID:21431798; http://dx.doi.org/10.1007/s12199-010-0182-x
9. Rahman A, Vahter M, Ekström EC, Persson LA. Arsenic exposure in pregnancy increases the risk of lower respiratory tract infection and diarrhea during infancy in Bangladesh. Environ Health Perspect 2011; 119:719-724. PMID:21147604; http://dx.doi.org/10.1289/ehp.1002265
10. Xie Y, Liu J, Benbrahim-Tallaa L, Ward JM, Logsdon D, Diwan BA, Waalkes MP. Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic. Toxicology 2007; 236:7-15. PMID:17451858; http://dx.doi.org/10.1016/j.tox.2007.03.021
11. Waalkes MP, Ward JM, Liu J, Diwan BA. Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol Appl Pharmacol 2003; 186:7-17. PMID:12583988; http://dx.doi.org/10.1016/S0041-008X(02)00022-4
12. Waalkes MP, Liu J, Germolec DR, Trempus CS, Cannon RE, Tokar EJ, Tennant RW, Ward JM, Diwan BA. Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics. Cancer Res 2008; 68:8278-8285. PMID:18922899; http://dx.doi.org/10.1158/0008-5472.CAN-08-2099
13. Waalkes MP, Liu J, Diwan BA. Transplacental arsenic carcinogenesis in mice. Toxicol Appl Pharmacol 2007; 222:271-280. PMID:17306315; http://dx.doi.org/10.1016/j.taap.2006.12.034
14. Tokar EJ, Qu W, Waalkes MP. Arsenic, stem cells, and the developmental basis of adult cancer. Toxicol Sci 2011; 120(Suppl 1):S192-S203. PMID:21071725; http://dx.doi.org/10.1093/toxsci/kfq342
15. Pilsner JR, Liu X, Ahsan H, Ilievski V, Slavkovich V, Levy D, Factor-Litvak P, Graziano JH, Gamble MV. Genomic methylation of peripheral blood leukocyte DNA: influences of arsenic and folate in Bangladeshi adults. Am J Clin Nutr 2007; 86:1179-1186. PMID:17921400
16. Chanda S, Dasgupta UB, Guhamazumder D, Gupta M, Chaudhuri U, Lahiri S, Das S, Ghosh N, Chatterjee D. DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol Sci 2006; 89:431-7. PMID:16251483; http://dx.doi.org/10.1093/toxsci/kfj030
17. Kile ML, Baccarelli A, Hoffman E, Tarantini L, Quamruzzaman Q, Rahman M, Mahiuddin G, Mostofa G, Hsueh YM, Wright RO, et al.Prenatal arsenic exposure and DNA methylation in maternal and umbilical cord blood leukocytes. Environ Health Perspect 2012; 120:1061-6. PMID:22466225; http://dx.doi.org/10.1289/ehp.1104173
18. Adalsteinsson BT, Gudnason H, Aspelund T, Harris TB, Launer LJ, Eiriksdottir G, Smith AV, Gudnason V. Heterogeneity in white blood cells has potential to confound DNA methylation measurements. PLoS One 2012; 7:e46705. PMID:23071618; http://dx.doi.org/10.1371/journal.pone.0046705
19. Koestler DC, Marsit CJ, Christensen BC, Accomando W, Langevin SM, Houseman EA, Nelson HH, Karagas MR, Wiencke JK, Kelsey KT. Peripheral blood immune cell methylation profiles are associated with nonhematopoietic cancers. Cancer Epidemiol Biomarkers Prev 2012; 21:1293-1302. PMID:22714737; http://dx.doi.org/10.1158/1055-9965.EPI-12-0361
20. Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, Wiencke JK, Kelsey KT. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics 2012; 13:86. PMID:22568884; http://dx.doi.org/10.1186/1471-2105-13-86
21. Lam LL, Emberly E, Fraser HB, Neumann SM, Chen E, Miller GE, Kobor MS. Factors underlying variable DNA methylation in a human community cohort. Proc Natl Acad Sci U S A 2012; 109(Suppl 2):17253-17260. PMID:23045638; http://dx.doi.org/10.1073/pnas.1121249109
22. Wieczorek G, Asemissen A, Model F, Turbachova I, Floess S, Liebenberg V, Baron U, Stauch D, Kotsch K, Pratschke J, et al.Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res 2009; 69:599-608. PMID:19147574; http://dx.doi.org/10.1158/0008-5472.CAN-08-2361
23. Liu Y, Aryee MJ, Padyukov L, Fallin MD, Hesselberg E, Runarsson A, Reinius L, Acevedo N, Taub M, Ronninger M, et al.Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat Biotechnol 2013; 31:142-7. PMID:23334450; http://dx.doi.org/10.1038/nbt.2487
24. Koestler DC, Christensen B, Karagas MR, Marsit CJ, Langevin SM, Kelsey KT, Wiencke JK, Houseman EA. Blood-based profiles of DNA methylation predict the underlying distribution of cell types: a validation analysis. Epigenetics 2013; 8:816-826. PMID:23903776; http://dx.doi.org/10.4161/epi.25430
25. Langevin SM, Koestler DC, Christensen BC, Butler RA, Wiencke JK, Nelson HH, Houseman EA, Marsit CJ, Kelsey KT. Peripheral blood DNA methylation profiles are indicative of head and neck squamous cell carcinoma: an epigenome-wide association study. Epigenetics 2012; 7:291-9. PMID:22430805; http://dx.doi.org/10.4161/epi.7.3.19134
26. Burns LA, Munson AE. Gallium arsenide selectively inhibits T cell proliferation and alters expression of CD25 (IL-2R/p55). J Pharmacol Exp Ther 1993; 265:178-186. PMID:8097242
27. Patterson R, Vega L, Trouba K, Bortner C, Germolec D. Arsenic-induced alterations in the contact hypersensitivity response in Balb/c mice. Toxicol Appl Pharmacol 2004; 198:434-443. PMID:15276424; http://dx.doi.org/10.1016/j.taap.2003.10.012
28. Sikorski EE, McCay JA, White KL Jr., Bradley SG, Munson AE. Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice. Fundam Appl Toxicol 1989; 13:843-858. PMID:2695379; http://dx.doi.org/10.1016/0272-0590(89)90338-2
29. Yoshida T, Shimamura T, Shigeta S. Enhancement of the immune response in vitro by arsenic. Int J Immunopharmacol 1987; 9:411-5. PMID:2956202; http://dx.doi.org/10.1016/0192-0561(87)90068-3
30. Lemarie A, Morzadec C, Mérino D, Micheau O, Fardel O, Vernhet L.Arsenic trioxide induces apoptosis of human monocytes during macrophagic differentiation through nuclear factor-kappaB-related survival pathway down-regulation. J Pharmacol Exp Ther 2006; 316:304-314. PMID:16174796; http://dx.doi.org/10.1124/jpet.105.092874
31. Lemarie A, Morzadec C, Bourdonnay E, Fardel O, Vernhet L.Human macrophages constitute targets for immunotoxic inorganic arsenic. J Immunol 2006; 177:3019-3027. PMID:16920938
32. Bourdonnay E, Morzadec C, Sparfel L, Galibert MD, Jouneau S, Martin-Chouly C, Fardel O, Vernhet L.Global effects of inorganic arsenic on gene expression profile in human macrophages. Mol Immunol 2009; 46:649-656. PMID:19128835; http://dx.doi.org/10.1016/j.molimm.2008.08.268
33. Conde P, Acosta-Saavedra LC, Goytia-Acevedo RC, Calderon-Aranda ES. Sodium arsenite-induced inhibition of cell proliferation is related to inhibition of IL-2 mRNA expression in mouse activated T cells. Arch Toxicol 2007; 81:251-9. PMID:17009048; http://dx.doi.org/10.1007/s00204-006-0152-7
34. Hernández-Castro B, Doníz-Padilla LM, Salgado-Bustamante M, Rocha D, Ortiz-Pérez MD, Jiménez-Capdeville ME, Portales-Pérez DP, Quintanar-Stephano A, González-Amaro R. Effect of arsenic on regulatory T cells. J Clin Immunol 2009; 29:461-9. PMID:19247822; http://dx.doi.org/10.1007/s10875-009-9280-1
35. de la Fuente H, Portales-Pérez D, Baranda L, Díaz-Barriga F, Saavedra-Alanís V, Layseca E, González-Amaro R. Effect of arsenic, cadmium and lead on the induction of apoptosis of normal human mononuclear cells. Clin Exp Immunol 2002; 129:69-77. PMID:12100024; http://dx.doi.org/10.1046/j.1365-2249.2002.01885.x
36. Galicia G, Leyva R, Tenorio EP, Ostrosky-Wegman P, Saavedra R. Sodium arsenite retards proliferation of PHA-activated T cells by delaying the production and secretion of IL-2. Int Immunopharmacol 2003; 3:671-682. PMID:12757736; http://dx.doi.org/10.1016/S1567-5769(03)00049-3
37. Martin-Chouly C, Morzadec C, Bonvalet M, Galibert MD, Fardel O, Vernhet L.Inorganic arsenic alters expression of immune and stress response genes in activated primary human T lymphocytes. Mol Immunol 2011; 48:956-965. PMID:21281968; http://dx.doi.org/10.1016/j.molimm.2011.01.005
38. Biswas D, Banerjee M, Sen G, Das JK, Banerjee A, Sau TJ, Pandit S, Giri AK, Biswas T. Mechanism of erythrocyte death in human population exposed to arsenic through drinking water. Toxicol Appl Pharmacol 2008; 230:57-66. PMID:18377941; http://dx.doi.org/10.1016/j.taap.2008.02.003
39. Adalsteinsson BT, Gudnason H, Aspelund T, Harris TB, Launer LJ, Eiriksdottir G, Smith AV, Gudnason V. Heterogeneity in white blood cells has potential to confound DNA methylation measurements. PLoS One 2012; 7:e46705. PMID:23071618; http://dx.doi.org/10.1371/journal.pone.0046705
40. Lee ST, Xiao Y, Muench MO, Xiao J, Fomin ME, Wiencke JK, Zheng S, Dou X, de Smith A, Chokkalingam A, et al.A global DNA methylation and gene expression analysis of early human B-cell development reveals a demethylation signature and transcription factor network. Nucleic Acids Res 2012; 40:11339-11351. PMID:23074194; http://dx.doi.org/10.1093/nar/gks957
41. Bock C, Beerman I, Lien WH, Smith ZD, Gu H, Boyle P, Gnirke A, Fuchs E, Rossi DJ, Meissner A. DNA methylation dynamics during in vivo differentiation of blood and skin stem cells. Mol Cell 2012; 47:633-647. PMID:22841485; http://dx.doi.org/10.1016/j.molcel.2012.06.019
42. Ivascu C, Wasserkort R, Lesche R, Dong J, Stein H, Thiel A, Eckhardt F. DNA methylation profiling of transcription factor genes in normal lymphocyte development and lymphomas. Int J Biochem Cell Biol 2007; 39:1523-1538. PMID:17433759; http://dx.doi.org/10.1016/j.biocel.2007.02.006
43. Hartwig A, Blessing H, Schwerdtle T, Walter I. Modulation of DNA repair processes by arsenic and selenium compounds. Toxicology 2003; 193:161-9. PMID:14599775; http://dx.doi.org/10.1016/j.tox.2003.08.004
44. Zhou X, Sun X, Cooper KL, Wang F, Liu KJ, Hudson LG. Arsenite interacts selectively with zinc finger proteins containing C3H1 or C4 motifs. J Biol Chem 2011; 286:22855-22863. PMID:21550982; http://dx.doi.org/10.1074/jbc.M111.232926
45. Yu D, Wang ZH, Cheng SB, Li HK, Chan HB, Chew EC. The effect of arsenic trioxide on the expression of Hsc and HNF4 in nuclear matrix proteins in HepG2 cells. Anticancer Res 2001; 21(4A):2553-9. PMID:11724321
46. States JC, Singh AV, Knudsen TB, Rouchka EC, Ngalame NO, Arteel GE, Piao Y, Ko MS. Prenatal arsenic exposure alters gene expression in the adult liver to a proinflammatory state contributing to accelerated atherosclerosis. PLoS One 2012; 7:e38713. PMID:22719926; http://dx.doi.org/10.1371/journal.pone.0038713
47. Griendling KK, Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 2000; 91:21-7. PMID:10967199; http://dx.doi.org/10.1016/S0167-0115(00)00136-1
48. Navas-Acien A, Sharrett AR, Silbergeld EK, Schwartz BS, Nachman KE, Burke TA, Guallar E. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol 2005; 162:1037-1049. PMID:16269585; http://dx.doi.org/10.1093/aje/kwi330
49. Yang HT, Chou HJ, Han BC, Huang SY. Lifelong inorganic arsenic compounds consumption affected blood pressure in rats. Food Chem Toxicol 2007; 45:2479-87. PMID:17688991; http://dx.doi.org/10.1016/j.fct.2007.05.024
50. Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qiu QY, Zhu J, Tang W, Sun GL, Yang KQ, et al.Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997; 89:3354-3360. PMID:9129042
51. Das S, Santra A, Lahiri S, Guha Mazumder DN. Implications of oxidative stress and hepatic cytokine (TNF-alpha and IL-6) response in the pathogenesis of hepatic collagenesis in chronic arsenic toxicity. Toxicol Appl Pharmacol 2005; 204:18-26. PMID:15781290; http://dx.doi.org/10.1016/j.taap.2004.08.010
52. Kile ML, Hoffman E, Hsueh YM, Afroz S, Quamruzzaman Q, Rahman M, Mahiuddin G, Ryan L, Christiani DC. Variability in biomarkers of arsenic exposure and metabolism in adults over time. Environ Health Perspect 2009; 117:455-460. PMID:19337522
53. Kile ML, Houseman EA, Rodrigues E, Smith TJ, Quamruzzaman Q, Rahman M, Mahiuddin G, Su L, Christiani DC. Toenail arsenic concentrations, GSTT1 gene polymorphisms, and arsenic exposure from drinking water. Cancer Epidemiol Biomarkers Prev 2005; 14:2419-2426. PMID:16214926; http://dx.doi.org/10.1158/1055-9965.EPI-05-0306
54. Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L, Lin SM. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics 2010; 11:587. PMID:21118553; http://dx.doi.org/10.1186/1471-2105-11-587
55. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007; 8:118-127. PMID:16632515; http://dx.doi.org/10.1093/biostatistics/kxj037
56. Smyth GK. Limma: linear models for microarray data. New York: Springer, 2005.
57. Ruppert D, Wand MP, Carroll RJ.Semiparametric Regression. Cambridge: Cambridge University Press, 2003.
58. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al.Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005; 102:15545-15550. PMID:16199517; http://dx.doi.org/10.1073/pnas.0506580102
59. Goeman JJ, Bühlmann P. Analyzing gene expression data in terms of gene sets: methodological issues. Bioinformatics 2007; 23:980-7. PMID:17303618; http://dx.doi.org/10.1093/bioinformatics/btm051